Anti-Parkinson Drugs and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Anti-Parkinson Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Parkinson Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Parkinson Drugs Overall Market Size
2.1 Global Anti-Parkinson Drugs Market Size: 2023 VS 2030
2.2 Global Anti-Parkinson Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-Parkinson Drugs Players in Global Market
3.2 Top Global Anti-Parkinson Drugs Companies Ranked by Revenue
3.3 Global Anti-Parkinson Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-Parkinson Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Anti-Parkinson Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Parkinson Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anti-Parkinson Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-Parkinson Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Parkinson Drugs Market Size Markets, 2023 & 2030
4.1.2 Dopaminergic
4.1.3 Dopamine Agonists
4.1.4 Enzyme Inhibitors
4.1.5 Others
4.2 By Type - Global Anti-Parkinson Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-Parkinson Drugs Revenue, 2019-2024
4.2.2 By Type - Global Anti-Parkinson Drugs Revenue, 2025-2030
4.2.3 By Type - Global Anti-Parkinson Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Parkinson Drugs Market Size, 2023 & 2030
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Stores
5.2 By Application - Global Anti-Parkinson Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-Parkinson Drugs Revenue, 2019-2024
5.2.2 By Application - Global Anti-Parkinson Drugs Revenue, 2025-2030
5.2.3 By Application - Global Anti-Parkinson Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Anti-Parkinson Drugs Market Size, 2023 & 2030
6.2 By Region - Global Anti-Parkinson Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-Parkinson Drugs Revenue, 2019-2024
6.2.2 By Region - Global Anti-Parkinson Drugs Revenue, 2025-2030
6.2.3 By Region - Global Anti-Parkinson Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Anti-Parkinson Drugs Revenue, 2019-2030
6.3.2 US Anti-Parkinson Drugs Market Size, 2019-2030
6.3.3 Canada Anti-Parkinson Drugs Market Size, 2019-2030
6.3.4 Mexico Anti-Parkinson Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Anti-Parkinson Drugs Revenue, 2019-2030
6.4.2 Germany Anti-Parkinson Drugs Market Size, 2019-2030
6.4.3 France Anti-Parkinson Drugs Market Size, 2019-2030
6.4.4 U.K. Anti-Parkinson Drugs Market Size, 2019-2030
6.4.5 Italy Anti-Parkinson Drugs Market Size, 2019-2030
6.4.6 Russia Anti-Parkinson Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Anti-Parkinson Drugs Market Size, 2019-2030
6.4.8 Benelux Anti-Parkinson Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Anti-Parkinson Drugs Revenue, 2019-2030
6.5.2 China Anti-Parkinson Drugs Market Size, 2019-2030
6.5.3 Japan Anti-Parkinson Drugs Market Size, 2019-2030
6.5.4 South Korea Anti-Parkinson Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Anti-Parkinson Drugs Market Size, 2019-2030
6.5.6 India Anti-Parkinson Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Anti-Parkinson Drugs Revenue, 2019-2030
6.6.2 Brazil Anti-Parkinson Drugs Market Size, 2019-2030
6.6.3 Argentina Anti-Parkinson Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-Parkinson Drugs Revenue, 2019-2030
6.7.2 Turkey Anti-Parkinson Drugs Market Size, 2019-2030
6.7.3 Israel Anti-Parkinson Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Anti-Parkinson Drugs Market Size, 2019-2030
6.7.5 UAE Anti-Parkinson Drugs Market Size, 2019-2030
7 Anti-Parkinson Drugs Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Anti-Parkinson Drugs Major Product Offerings
7.1.4 AbbVie Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.1.5 AbbVie Key News & Latest Developments
7.2 Mylan Laboratories
7.2.1 Mylan Laboratories Company Summary
7.2.2 Mylan Laboratories Business Overview
7.2.3 Mylan Laboratories Anti-Parkinson Drugs Major Product Offerings
7.2.4 Mylan Laboratories Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.2.5 Mylan Laboratories Key News & Latest Developments
7.3 Valeant Pharmaceuticals
7.3.1 Valeant Pharmaceuticals Company Summary
7.3.2 Valeant Pharmaceuticals Business Overview
7.3.3 Valeant Pharmaceuticals Anti-Parkinson Drugs Major Product Offerings
7.3.4 Valeant Pharmaceuticals Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.3.5 Valeant Pharmaceuticals Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Anti-Parkinson Drugs Major Product Offerings
7.4.4 Novartis Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.4.5 Novartis Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Anti-Parkinson Drugs Major Product Offerings
7.5.4 GlaxoSmithKline Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Zambon Pharmaceuticals
7.6.1 Zambon Pharmaceuticals Company Summary
7.6.2 Zambon Pharmaceuticals Business Overview
7.6.3 Zambon Pharmaceuticals Anti-Parkinson Drugs Major Product Offerings
7.6.4 Zambon Pharmaceuticals Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.6.5 Zambon Pharmaceuticals Key News & Latest Developments
7.7 Pfizer, Inc.
7.7.1 Pfizer, Inc. Company Summary
7.7.2 Pfizer, Inc. Business Overview
7.7.3 Pfizer, Inc. Anti-Parkinson Drugs Major Product Offerings
7.7.4 Pfizer, Inc. Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.7.5 Pfizer, Inc. Key News & Latest Developments
7.8 Hoffmann-La Roche
7.8.1 Hoffmann-La Roche Company Summary
7.8.2 Hoffmann-La Roche Business Overview
7.8.3 Hoffmann-La Roche Anti-Parkinson Drugs Major Product Offerings
7.8.4 Hoffmann-La Roche Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.8.5 Hoffmann-La Roche Key News & Latest Developments
7.9 Merck & Co.
7.9.1 Merck & Co. Company Summary
7.9.2 Merck & Co. Business Overview
7.9.3 Merck & Co. Anti-Parkinson Drugs Major Product Offerings
7.9.4 Merck & Co. Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.9.5 Merck & Co. Key News & Latest Developments
7.10 Orion Pharma
7.10.1 Orion Pharma Company Summary
7.10.2 Orion Pharma Business Overview
7.10.3 Orion Pharma Anti-Parkinson Drugs Major Product Offerings
7.10.4 Orion Pharma Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.10.5 Orion Pharma Key News & Latest Developments
7.11 UCB
7.11.1 UCB Company Summary
7.11.2 UCB Business Overview
7.11.3 UCB Anti-Parkinson Drugs Major Product Offerings
7.11.4 UCB Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.11.5 UCB Key News & Latest Developments
7.12 Teva Pharmaceutical Industries Ltd.
7.12.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.12.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.12.3 Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Major Product Offerings
7.12.4 Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.12.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.13 Vertical Pharmaceuticals, LLC
7.13.1 Vertical Pharmaceuticals, LLC Company Summary
7.13.2 Vertical Pharmaceuticals, LLC Business Overview
7.13.3 Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Major Product Offerings
7.13.4 Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.13.5 Vertical Pharmaceuticals, LLC Key News & Latest Developments
7.14 ACADIA Pharmaceuticals Inc.
7.14.1 ACADIA Pharmaceuticals Inc. Company Summary
7.14.2 ACADIA Pharmaceuticals Inc. Business Overview
7.14.3 ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Major Product Offerings
7.14.4 ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Revenue in Global Market (2019-2024)
7.14.5 ACADIA Pharmaceuticals Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Anti-Parkinson Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-Parkinson Drugs Market Drivers in Global Market
Table 3. Anti-Parkinson Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-Parkinson Drugs in Global Market
Table 5. Top Anti-Parkinson Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Anti-Parkinson Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Anti-Parkinson Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Anti-Parkinson Drugs Product Type
Table 9. List of Global Tier 1 Anti-Parkinson Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Parkinson Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Anti-Parkinson Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Anti-Parkinson Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Anti-Parkinson Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Anti-Parkinson Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Anti-Parkinson Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Anti-Parkinson Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Anti-Parkinson Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Anti-Parkinson Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Anti-Parkinson Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Anti-Parkinson Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Anti-Parkinson Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Anti-Parkinson Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Anti-Parkinson Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Anti-Parkinson Drugs Revenue, (US$, Mn), 2025-2030
Table 30. AbbVie Company Summary
Table 31. AbbVie Anti-Parkinson Drugs Product Offerings
Table 32. AbbVie Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. AbbVie Key News & Latest Developments
Table 34. Mylan Laboratories Company Summary
Table 35. Mylan Laboratories Anti-Parkinson Drugs Product Offerings
Table 36. Mylan Laboratories Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. Mylan Laboratories Key News & Latest Developments
Table 38. Valeant Pharmaceuticals Company Summary
Table 39. Valeant Pharmaceuticals Anti-Parkinson Drugs Product Offerings
Table 40. Valeant Pharmaceuticals Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. Valeant Pharmaceuticals Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Anti-Parkinson Drugs Product Offerings
Table 44. Novartis Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. Novartis Key News & Latest Developments
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Anti-Parkinson Drugs Product Offerings
Table 48. GlaxoSmithKline Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Zambon Pharmaceuticals Company Summary
Table 51. Zambon Pharmaceuticals Anti-Parkinson Drugs Product Offerings
Table 52. Zambon Pharmaceuticals Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. Zambon Pharmaceuticals Key News & Latest Developments
Table 54. Pfizer, Inc. Company Summary
Table 55. Pfizer, Inc. Anti-Parkinson Drugs Product Offerings
Table 56. Pfizer, Inc. Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. Pfizer, Inc. Key News & Latest Developments
Table 58. Hoffmann-La Roche Company Summary
Table 59. Hoffmann-La Roche Anti-Parkinson Drugs Product Offerings
Table 60. Hoffmann-La Roche Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 61. Hoffmann-La Roche Key News & Latest Developments
Table 62. Merck & Co. Company Summary
Table 63. Merck & Co. Anti-Parkinson Drugs Product Offerings
Table 64. Merck & Co. Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 65. Merck & Co. Key News & Latest Developments
Table 66. Orion Pharma Company Summary
Table 67. Orion Pharma Anti-Parkinson Drugs Product Offerings
Table 68. Orion Pharma Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 69. Orion Pharma Key News & Latest Developments
Table 70. UCB Company Summary
Table 71. UCB Anti-Parkinson Drugs Product Offerings
Table 72. UCB Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 73. UCB Key News & Latest Developments
Table 74. Teva Pharmaceutical Industries Ltd. Company Summary
Table 75. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Product Offerings
Table 76. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 77. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 78. Vertical Pharmaceuticals, LLC Company Summary
Table 79. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Product Offerings
Table 80. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 81. Vertical Pharmaceuticals, LLC Key News & Latest Developments
Table 82. ACADIA Pharmaceuticals Inc. Company Summary
Table 83. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Product Offerings
Table 84. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Revenue (US$, Mn) & (2019-2024)
Table 85. ACADIA Pharmaceuticals Inc. Key News & Latest Developments
List of Figures
Figure 1. Anti-Parkinson Drugs Segment by Type in 2023
Figure 2. Anti-Parkinson Drugs Segment by Application in 2023
Figure 3. Global Anti-Parkinson Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Anti-Parkinson Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Anti-Parkinson Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-Parkinson Drugs Revenue in 2023
Figure 8. By Type - Global Anti-Parkinson Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Anti-Parkinson Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Anti-Parkinson Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Anti-Parkinson Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Anti-Parkinson Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Anti-Parkinson Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Anti-Parkinson Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Anti-Parkinson Drugs Revenue Market Share, 2019-2030
Figure 16. US Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Anti-Parkinson Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Anti-Parkinson Drugs Revenue Market Share, 2019-2030
Figure 28. China Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Anti-Parkinson Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Anti-Parkinson Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Anti-Parkinson Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. AbbVie Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Mylan Laboratories Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Valeant Pharmaceuticals Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Novartis Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. GlaxoSmithKline Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Zambon Pharmaceuticals Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Pfizer, Inc. Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Hoffmann-La Roche Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Merck & Co. Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Orion Pharma Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. UCB Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)